Genitourinary syndrome of menopause and the role of biostimulation with non-cross-linked injectable hyaluronic acid plus calcium hydroxyapatite

J Biol Regul Homeost Agents. 2019 Nov-Dec;33(6):1961-1966. doi: 10.23812/19-251-L..
No abstract available

Keywords: genitourinary; menopause; vulvovaginal atrophy.

Publication types

  • Letter

MeSH terms

  • Durapatite / therapeutic use*
  • Female
  • Female Urogenital Diseases / therapy*
  • Humans
  • Hyaluronic Acid / therapeutic use*
  • Menopause*
  • Syndrome

Substances

  • Hyaluronic Acid
  • Durapatite